Immunology Exam Questions and Answers with Explanation

Immunology is one of the most dynamic and challenging areas in the health sciences. Whether you are preparing for a university course, a medical board exam, or a professional certification, success depends on a clear understanding of both basic concepts and their clinical applications. The Immunology Practice Exam is designed to provide students, healthcare trainees, and professionals with a reliable tool to assess knowledge and strengthen test-taking skills. Through carefully structured immunology practice exam questions and answers, this resource mimics real testing conditions while ensuring every major topic in immunity is covered in depth.

This Immunology Exam Practice Test with Questions and Answers is designed to give you that advantage. The practice questions reflect the structure, wording, and cognitive level typically seen on academic and certification exams, and each question includes a detailed explanation so you understand why the correct answer is right, and how it connects to core immunological principles. That deeper insight helps you improve recall, strengthen reasoning, and study with purpose instead of memorizing disconnected facts.

Rather than overwhelming you with unfocused content, this exam concentrates on the topics that matter most — innate and adaptive immunity, antigen processing, immunogenetics, hypersensitivity, and clinical applications of immune responses. Whether you’re preparing for a course final, graduate entrance exam, or professional assessment, this resource helps you identify weak areas, reinforce critical concepts, and walk into your test with confidence.

Who Can Take This Immunology Exam Practice Test?

• Undergraduate and graduate students in biology, medicine, pharmacy, and nursing who need structured revision.
• Medical students preparing for midterms, finals, or board exams with heavy immunology components.
• Healthcare professionals seeking continuing education or refresher knowledge.
• Researchers and lab scientists aiming to strengthen conceptual frameworks in applied immunology.

This Immunology Practice Test is Useful For:

• Building confidence before high-stakes exams.
• Identifying weak areas through targeted immunology practice questions.
• Practicing applied reasoning with clinical-style immunity practice test scenarios.
• Reinforcing theoretical learning with structured immunology exams with answers.

About the Immunology Practice Exam

The exam is structured around the major domains of immunology, blending basic immunology exam questions with clinically relevant case-based scenarios. It is organized in a question-and-answer format to replicate the actual testing style most candidates will face. Each answer is supported with a detailed explanation, allowing students not only to confirm whether they chose correctly but also to understand why. This approach transforms testing from simple recall into active learning.

The immunology exams with answers are updated with current knowledge, ensuring alignment with the most recent scientific findings and medical guidelines. This is especially important in fields like immunotherapy and vaccine development, where the science changes quickly.

Cover Topics in Our Immunology Practice Exam

The questions span across the entire immunology curriculum. Below is a structured overview of what the exam covers, reflecting the content from the practice sets:

1. Innate Immunity

   • Recognition of pathogens through toll-like receptors (TLR3, TLR4, TLR7, TLR9).
   • Antimicrobial peptides such as defensins.
   • The role of neutrophils, macrophages, NK cells, and dendritic cells.
   • Cytokines driving inflammation (IL-1, IL-6, TNF-α).

2. Adaptive Immunity

   • T-cell subsets: Th1, Th2, Th17, Tfh, and Tregs.
   • Cytokine drivers of differentiation (IL-4, IL-12, TGF-β, IL-6, IL-23).
   • CD8+ cytotoxic mechanisms via perforin and granzymes.
   • B-cell activation, class switching, and affinity maturation with IL-21 and CD40L signaling.

3. Antibodies and Immunoglobulins

   • Functional roles of IgM, IgG, IgA, IgE, and IgG subclasses.
   • Special features like IgG4’s anti-inflammatory properties and IgA in breast milk.
   • Antibody effector functions: complement activation, opsonization, neutralization, and placental transfer.

4. Complement System

   • Classical, alternative, and lectin pathways.
   • Key effector molecules: C3b as opsonin, C5a as chemoattractant, C9 as MAC pore former.
   • Regulatory proteins such as CD59, Factor H, and C1 inhibitor.
   • Clinical correlations: C1q deficiency in lupus, C5-C9 deficiency in recurrent Neisseria infections.

5. Hypersensitivity Reactions

   • Type I: IgE-mediated allergy and anaphylaxis.
   • Type II: Autoantibody-mediated cytotoxicity (autoimmune hemolytic anemia, myasthenia gravis, rheumatic fever).
   • Type III: Immune complex diseases (SLE, serum sickness, post-streptococcal glomerulonephritis, Arthus reaction).
   • Type IV: T-cell mediated delayed hypersensitivity (TB skin test, contact dermatitis, type 1 diabetes).

6. Immunodeficiency Syndromes

   • Primary: X-linked agammaglobulinemia, Hyper-IgM syndrome, SCID, DiGeorge, Wiskott–Aldrich, IPEX.
   • Secondary: HIV/AIDS, chemotherapy-induced immune suppression.
   • Clinical patterns of susceptibility (bacteria in B-cell defects, viruses in T-cell defects, fungi in neutrophil dysfunction).

7. Autoimmunity and Clinical Immunology

   • Hashimoto thyroiditis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus.
   • Mechanisms of tolerance failure (central and peripheral tolerance, Treg dysfunction).
   • The role of HLA associations (e.g., HLA-B27 in ankylosing spondylitis).

8. Vaccines and Immunotherapy

   • Live attenuated vs. inactivated vaccines, subunit and toxoid vaccines.
   • Safety considerations in pregnancy and immunocompromised individuals.
   • Checkpoint inhibitors (CTLA-4, PD-1/PD-L1).
   • CAR-T therapy and cytokine release syndrome (IL-6 involvement).

This broad coverage ensures the exam reflects the depth and breadth of what immunology students need to know. It incorporates both immunity practice questions for fundamentals and advanced clinical correlations through immunology practice exam questions and answers.

How to Study Immunology Effectively

Immunology can be intimidating because of the sheer volume of molecules, pathways, and diseases. But with the right strategies, you can simplify the complexity:

1. Start with Foundations: Understand innate immunity, barrier defenses, and the general structure of antibodies. This sets the stage for the adaptive immune system.
2. Use Active Recall: Practice regularly with immunity practice questions rather than just reading notes. Retrieval practice strengthens long-term memory.
3. Make Pathways Visual: Draw diagrams of complement cascades, T-cell differentiation, and antibody functions. Visual learning reinforces conceptual connections.
4. Link Clinical Cases: Always tie mechanisms back to diseases (e.g., C1q deficiency → lupus, FOXP3 mutation → IPEX). This contextualizes abstract content.
5. Review with Repetition: Immunology concepts fade fast without repetition. Use spaced repetition with flashcards and timed quizzes.

Study Tips to Pass the Immunology Exam

1. Practice, Don’t Just Read: Work through as many immunology practice exam questions and answers as possible. This builds test-taking speed and confidence.
2. Focus on High-Yield Areas: Hypersensitivity reactions, immunodeficiency syndromes, vaccines, and cytokines are frequently tested.
3. Simulate Exam Conditions: Use timed immunity practice test sessions to replicate exam pressure.
4. Check Explanations Thoroughly: Whether you get the answer right or wrong, read the explanations carefully. They often contain subtle points that reappear in exams.
5. Integrate Clinical Relevance: Remember that examiners love applied reasoning. Be prepared for questions linking molecular pathways to patient scenarios.
6. Balance Breadth and Depth: Don’t only memorize molecules—know their functional consequences and how they interact across systems.

Immunology is a subject that requires both memorization and deep conceptual understanding. By engaging with structured immunology practice questions, students and professionals gain not only knowledge but also exam-ready confidence. This immunology practice exam is a comprehensive tool to test, refine, and apply your learning. With detailed explanations, broad topic coverage, and clinically relevant scenarios, it transforms preparation from rote study into mastery.

Whether you are looking for basic immunology exam questions for revision or challenging case-based immunity practice test material for board readiness, this exam resource provides everything you need. With consistent effort, smart study strategies, and a focus on understanding, you’ll be well-equipped to succeed in any immunology exam questions you face.

Immunology Sample Questions and Answers

Q1. Which immune cells are the primary producers of antibodies?

A) Macrophages
B) B lymphocytes
C) T helper cells
D) Dendritic cells

Answer: B) B lymphocytes

Explanation:
B lymphocytes are central to the adaptive immune system because they differentiate into plasma cells, which secrete antibodies (immunoglobulins). These antibodies can neutralize toxins, block pathogen entry, and facilitate opsonization for phagocytosis. Macrophages and dendritic cells are primarily antigen-presenting cells, while T helper cells aid in activating B cells but do not directly produce antibodies. The ability of B cells to undergo class switching and memory formation makes them critical for both immediate and long-term humoral immunity.

Q2. Which molecule is recognized by Toll-like receptor 4 (TLR4)?

A) Viral double-stranded RNA
B) Lipopolysaccharide (LPS)
C) Bacterial flagellin
D) Peptidoglycan

Answer: B) Lipopolysaccharide (LPS)

Explanation:
TLR4 is a pattern recognition receptor that recognizes lipopolysaccharide, a key component of the outer membrane of Gram-negative bacteria. This detection activates downstream signaling pathways, leading to NF-κB activation and the production of pro-inflammatory cytokines such as TNF-α and IL-6. Viral dsRNA is detected by TLR3, bacterial flagellin by TLR5, and peptidoglycan mainly by NOD receptors. TLR4 recognition of LPS is crucial for initiating strong innate immune responses but also linked to sepsis if uncontrolled.

Q3. Which immunoglobulin is most abundant in mucosal secretions?

A) IgA
B) IgG
C) IgM
D) IgE

Answer: A) IgA

Explanation:
Secretory IgA is the dominant immunoglobulin in mucosal surfaces such as saliva, tears, breast milk, and intestinal secretions. It forms dimers linked by the J-chain and is transported across epithelial cells with the secretory component, which protects it from enzymatic degradation. IgA plays a frontline role by neutralizing pathogens and toxins before they cross epithelial barriers. IgG is more abundant in serum, IgM is the first antibody produced in primary responses, and IgE is involved in allergic reactions and defense against parasites.

Q4. Which cells are the main antigen-presenting cells (APCs) responsible for priming naïve T cells?

A) Neutrophils
B) Dendritic cells
C) Natural killer cells
D) Eosinophils

Answer: B) Dendritic cells

Explanation:
Dendritic cells are the most potent professional antigen-presenting cells. They capture antigens at peripheral sites, process them, and migrate to lymph nodes where they present peptides on MHC molecules to naïve T cells. This interaction, along with co-stimulatory signals, is essential for initiating adaptive immune responses. Neutrophils are efficient at killing microbes but are poor APCs. NK cells target infected or abnormal cells without antigen presentation, and eosinophils specialize in parasitic defense. The central role of dendritic cells makes them key in vaccine design.

Q5. What is the primary function of cytotoxic CD8+ T cells?

A) Activate B cells
B) Present antigens to other T cells
C) Kill virus-infected and tumor cells
D) Produce histamine

Answer: C) Kill virus-infected and tumor cells

Explanation:
Cytotoxic CD8+ T cells directly kill cells presenting foreign or abnormal antigens in association with MHC class I molecules. They release perforin and granzymes, inducing apoptosis in the target cell. They also secrete IFN-γ to enhance immune responses. CD4+ T helper cells are the ones that activate B cells, while antigen presentation is mainly carried out by dendritic cells, macrophages, and B cells. Histamine release is the function of mast cells and basophils. CD8+ T cells are vital for controlling viral infections and eliminating malignant cells.

Q6. Which cytokine is critical for the differentiation of naïve CD4+ T cells into Th1 cells?

A) IL-4
B) IL-12
C) IL-10
D) IL-17

Answer: B) IL-12

Explanation:
IL-12 is produced by dendritic cells and macrophages during microbial infections. It drives the differentiation of naïve CD4+ T cells into Th1 cells, which produce IFN-γ. Th1 cells are essential for cell-mediated immunity, especially against intracellular pathogens like viruses and certain bacteria. IL-4 promotes Th2 differentiation, IL-10 is an anti-inflammatory cytokine, and IL-17 is produced by Th17 cells. By skewing toward Th1, IL-12 enhances macrophage activation and cytotoxic T cell responses, making it a central cytokine in protective immunity.

Q7. Which complement pathway is activated by antigen-antibody complexes?

A) Classical pathway
B) Lectin pathway
C) Alternative pathway
D) Properdin pathway

Answer: A) Classical pathway

Explanation:
The classical complement pathway is triggered when antibodies (IgM or IgG) bind to antigens, forming immune complexes. C1q binds to the Fc region of these antibodies, initiating a cascade that leads to opsonization, inflammation, and formation of the membrane attack complex (MAC). The lectin pathway is activated by mannose-binding lectin recognizing carbohydrates on microbes, and the alternative pathway is continuously activated at low levels through spontaneous hydrolysis of C3. Properdin stabilizes the alternative pathway but is not a separate activation route.

Q8. Which MHC molecules present antigens to CD4+ T cells?

A) MHC class I
B) MHC class II
C) β2-microglobulin
D) TAP transporter

Answer: B) MHC class II

Explanation:
MHC class II molecules are expressed on professional APCs (dendritic cells, macrophages, B cells). They present exogenous peptides derived from extracellular pathogens to CD4+ T helper cells. This recognition is essential for initiating helper functions such as B cell activation and cytokine production. MHC class I presents endogenous antigens to CD8+ T cells. β2-microglobulin is a component of MHC class I molecules, while TAP is a transporter that loads peptides onto MHC class I in the endoplasmic reticulum.

Q9. Which hypersensitivity reaction type is mediated by IgE antibodies?

A) Type I
B) Type II
C) Type III
D) Type IV

Answer: A) Type I

Explanation:
Type I hypersensitivity is also known as immediate hypersensitivity and involves IgE antibodies binding to FcεRI receptors on mast cells and basophils. Upon re-exposure to the allergen, cross-linking of IgE causes rapid degranulation, releasing histamine and other mediators, leading to allergic responses like hay fever, asthma, or anaphylaxis. Type II involves antibody-mediated cytotoxicity, Type III involves immune complex deposition, and Type IV is delayed-type hypersensitivity mediated by T cells. Type I is the only hypersensitivity reaction that involves IgE directly.

Q10. Which of the following is a primary lymphoid organ?

A) Lymph nodes
B) Spleen
C) Thymus
D) Peyer’s patches

Answer: C) Thymus

Explanation:
The thymus is a primary lymphoid organ where T cells mature and undergo positive and negative selection to ensure proper recognition of self and non-self. Primary lymphoid organs are where lymphocytes develop (bone marrow for B cells, thymus for T cells). Secondary lymphoid organs—such as lymph nodes, spleen, and mucosal-associated tissues like Peyer’s patches—are sites where mature lymphocytes encounter antigens and initiate immune responses. Without thymic education, T cells would lack self-tolerance, leading to autoimmunity.

Q11. Which enzyme is responsible for generating antibody diversity through somatic recombination?

A) DNA polymerase
B) RAG-1 and RAG-2
C) RNA polymerase
D) Telomerase

Answer: B) RAG-1 and RAG-2

Explanation:
Recombination-activating genes (RAG-1 and RAG-2) are essential for somatic recombination of immunoglobulin and T-cell receptor genes. This process generates the vast diversity needed to recognize countless antigens. RAG enzymes cut and rejoin V (variable), D (diversity), and J (joining) segments to create unique antigen-binding regions. DNA and RNA polymerases are involved in replication and transcription but not recombination. Telomerase maintains chromosome ends. Without RAG activity, severe combined immunodeficiency (SCID) develops, showing its essential role in adaptive immunity.

Q12. Which immune cells are the first to arrive at sites of acute infection?

A) Eosinophils
B) Neutrophils
C) NK cells
D) Basophils

Answer: B) Neutrophils

Explanation:
Neutrophils are the most abundant white blood cells and the first responders during acute inflammation. They rapidly migrate to infected tissues in response to chemokines like IL-8. Neutrophils engulf and kill microbes via phagocytosis, release reactive oxygen species, and form neutrophil extracellular traps (NETs). Eosinophils are more active in parasitic and allergic responses. NK cells attack abnormal cells but are slower to mobilize. Basophils contribute to allergic inflammation but are rare. Neutrophils’ fast response makes them critical in the early defense against bacterial infections.

Q13. Which cytokine is key for the survival and proliferation of T regulatory (Treg) cells?

A) IL-2
B) IL-5
C) IL-7
D) IFN-γ

Answer: A) IL-2

Explanation:
IL-2, produced by activated T cells, is essential not only for effector T cell proliferation but also for the development and maintenance of regulatory T cells (Tregs). Tregs express high-affinity IL-2 receptors (CD25) and use IL-2 to maintain their suppressive functions. Without adequate IL-2, Treg activity weakens, leading to autoimmunity. IL-5 primarily supports eosinophil growth, IL-7 is crucial for early lymphocyte development, and IFN-γ is a Th1 cytokine for macrophage activation. Thus, IL-2 is indispensable for balancing immune activation and tolerance.

Q14. Which of the following vaccines is a live attenuated vaccine?

A) Hepatitis B
B) Polio (Sabin)
C) Tetanus toxoid
D) Influenza (inactivated)

Answer: B) Polio (Sabin)

Explanation:
Live attenuated vaccines contain weakened pathogens that can still replicate but do not cause disease in healthy individuals. Examples include the Sabin polio vaccine, MMR, and varicella vaccines. They stimulate strong cellular and humoral immunity, often with long-lasting protection. Hepatitis B uses a recombinant subunit vaccine, tetanus toxoid is inactivated toxin (toxoid vaccine), and inactivated influenza vaccines contain killed viral particles. While live attenuated vaccines provide robust immunity, they are not suitable for immunocompromised individuals or pregnant women.

Q15. Which process allows B cells to improve antibody affinity after activation?

A) V(D)J recombination
B) Somatic hypermutation
C) Class switching
D) Alternative splicing

Answer: B) Somatic hypermutation

Explanation:
Somatic hypermutation occurs in germinal centers of lymph nodes after B cell activation. The enzyme activation-induced cytidine deaminase (AID) introduces mutations into the variable region of immunoglobulin genes. B cells with higher affinity for antigen are selected to survive, a process called affinity maturation. V(D)J recombination happens earlier during B cell development. Class switching changes antibody isotype (IgM → IgG, IgA, IgE) but not affinity. Alternative splicing alters mRNA products but does not increase affinity. This mechanism ensures progressively stronger antibody responses upon re-exposure.

Q16. Which immunoglobulin is responsible for mediating allergic reactions and defense against parasites?

A) IgA
B) IgM
C) IgE
D) IgG

Answer: C) IgE

Explanation:
IgE binds to Fc receptors on mast cells and basophils. Upon allergen exposure, cross-linking of IgE triggers degranulation and release of histamine, leukotrienes, and other mediators, leading to allergic symptoms such as asthma, rhinitis, and anaphylaxis. IgE also plays a protective role against helminths and parasites by activating eosinophils. IgA is critical in mucosal defense, IgM is the first antibody produced in primary responses, and IgG is the most abundant antibody in serum with versatile functions. IgE’s role is unique in immediate hypersensitivity reactions.

Q17. Which molecule is essential for antigen transport into the endoplasmic reticulum for MHC class I loading?

A) TAP transporter
B) β2-microglobulin
C) Calnexin
D) CLIP protein

Answer: A) TAP transporter

Explanation:
Transporter associated with antigen processing (TAP) shuttles peptides derived from cytosolic proteins into the endoplasmic reticulum, where they are loaded onto MHC class I molecules. This allows CD8+ T cells to monitor intracellular antigens, including viral peptides. β2-microglobulin stabilizes MHC class I structure, calnexin assists in folding, and CLIP is involved in MHC class II peptide loading. Without TAP, peptides cannot be efficiently presented to CD8+ T cells, resulting in immune deficiencies and susceptibility to viral infections.

Q18. Which cytokine is most associated with promoting eosinophil activation?

A) IL-4
B) IL-5
C) IL-12
D) TNF-α

Answer: B) IL-5

Explanation:
IL-5 is produced mainly by Th2 cells and is the key cytokine that drives eosinophil growth, differentiation, and activation. Eosinophils play crucial roles in combating parasitic infections and contribute to allergic diseases like asthma. IL-4 promotes IgE production, IL-12 promotes Th1 differentiation, and TNF-α is a major pro-inflammatory cytokine. The IL-5–eosinophil axis is a therapeutic target in severe asthma, where anti-IL-5 monoclonal antibodies are used to reduce exacerbations.

Q19. Which signaling molecule is critical for T cell activation along with TCR engagement?

A) CD28
B) CD40
C) CTLA-4
D) CD56

Answer: A) CD28

Explanation:
T cell activation requires two signals: (1) antigen recognition via TCR binding to MHC and (2) co-stimulation, usually CD28 binding to B7 (CD80/CD86) on antigen-presenting cells. Without this co-stimulation, T cells may become anergic. CD40 is expressed on B cells and APCs and interacts with CD40L on T helper cells to enhance B cell responses. CTLA-4 is an inhibitory receptor that competes with CD28, dampening immune activation. CD56 is a marker for NK cells, not T cells. Co-stimulation ensures controlled activation and prevents autoimmunity.

Q20. Which immunodeficiency is caused by failure of thymic development?

A) Bruton’s agammaglobulinemia
B) DiGeorge syndrome
C) Chronic granulomatous disease
D) Severe combined immunodeficiency (SCID)

Answer: B) DiGeorge syndrome

Explanation:
DiGeorge syndrome results from defective development of the third and fourth pharyngeal pouches, leading to thymic aplasia or hypoplasia. Without a thymus, T cell development is severely impaired, causing recurrent viral, fungal, and protozoal infections. Bruton’s disease is a B cell defect due to absent BTK kinase, CGD is caused by defective NADPH oxidase in phagocytes, and SCID represents combined T and B cell defects due to genetic mutations. Thymic defects in DiGeorge also result in hypocalcemia due to parathyroid gland absence.

Q21. Which immune checkpoint receptor is targeted by the drug pembrolizumab?

A) PD-1
B) CTLA-4
C) CD28
D) CD19

Answer: A) PD-1

Explanation:
Pembrolizumab is a monoclonal antibody that blocks PD-1 (programmed death-1) receptor on T cells. Normally, PD-1 binding to its ligands PD-L1/PD-L2 inhibits T cell activity to maintain tolerance and prevent overactivation. Many tumors exploit this pathway by overexpressing PD-L1, effectively turning off T cells. By blocking PD-1, pembrolizumab reactivates T cells against cancer. CTLA-4 is targeted by ipilimumab, CD28 provides co-stimulation, and CD19 is a B cell marker targeted in CAR-T therapy. Immune checkpoint blockade revolutionized cancer immunotherapy.

Q22. Which antibody isotype can cross the placenta to provide passive immunity to the fetus?

A) IgA
B) IgM
C) IgG
D) IgE

Answer: C) IgG

Explanation:
IgG is the only immunoglobulin that efficiently crosses the placenta via neonatal Fc receptors (FcRn). This provides the newborn with passive immunity against pathogens until its own immune system matures. IgA is abundant in breast milk and protects mucosal surfaces, but it does not cross the placenta. IgM is too large (pentameric) to cross, and IgE is involved in allergic reactions. Maternal IgG antibodies are crucial for neonatal defense, but maternal infections or autoantibodies can also be transferred and cause neonatal diseases.

Q23. Which cell type is most important in antibody class switching?

A) Cytotoxic T cells
B) T helper cells (CD4+)
C) Natural killer cells
D) Dendritic cells

Answer: B) T helper cells (CD4+)

Explanation:
Class switching in B cells depends on signals from CD4+ T helper cells, specifically via CD40–CD40L interactions and cytokines. For example, IL-4 promotes switching to IgE and IgG, while TGF-β promotes switching to IgA. Cytotoxic T cells kill infected cells, NK cells function in innate immunity, and dendritic cells initiate T cell activation but do not drive class switching directly. Without T helper signals, B cells remain stuck producing IgM, leading to immunodeficiency conditions like Hyper-IgM syndrome.

Q24. Which hypersensitivity type underlies autoimmune hemolytic anemia?

A) Type I
B) Type II
C) Type III
D) Type IV

Answer: B) Type II

Explanation:
Type II hypersensitivity reactions involve antibodies (IgG or IgM) binding to self-cell surface antigens, leading to complement activation and cell destruction. In autoimmune hemolytic anemia, antibodies target red blood cells, resulting in their premature lysis. Type I is IgE-mediated allergy, Type III involves immune complex deposition (e.g., lupus), and Type IV is T cell–mediated delayed-type hypersensitivity (e.g., tuberculosis skin test). Autoimmune hemolytic anemia is a clear example of type II cytotoxic hypersensitivity.

Q25. Which cells play a major role in eliminating virus-infected cells in the innate immune response?

A) B lymphocytes
B) Macrophages
C) Natural killer (NK) cells
D) Eosinophils

Answer: C) Natural killer (NK) cells

Explanation:
NK cells recognize and kill virus-infected or transformed cells without prior sensitization. They detect reduced expression of MHC class I molecules, a common viral evasion strategy, and respond by releasing perforin and granzymes. B cells need T cell help to produce antibodies and belong to adaptive immunity. Macrophages engulf pathogens but are less effective at directly killing infected host cells. Eosinophils target helminths, not viruses. NK cells bridge innate and adaptive immunity, providing critical defense before T cell responses develop.

Q26. Which enzyme is critical for class switch recombination in B cells?

A) RAG-1
B) Activation-induced cytidine deaminase (AID)
C) DNA polymerase δ
D) RNA polymerase II

Answer: B) Activation-induced cytidine deaminase (AID)

Explanation:
AID initiates class switch recombination and somatic hypermutation by deaminating cytosine to uracil in DNA, leading to double-strand breaks that allow recombination between switch regions. This process changes the antibody isotype (e.g., IgM → IgG, IgA, or IgE) without altering antigen specificity. RAG-1 is important earlier during V(D)J recombination, not class switching. DNA polymerase and RNA polymerase are general enzymes but not directly involved. Without AID, patients develop Hyper-IgM syndrome with impaired antibody diversity.

Q27. Which immune response is primarily stimulated by polysaccharide vaccines without a protein carrier?

A) T-independent B cell response
B) T-dependent B cell response
C) Cytotoxic T cell response
D) Th17 cell response

Answer: A) T-independent B cell response

Explanation:
Polysaccharide vaccines (like the original pneumococcal vaccine) activate B cells directly without T cell help, leading to a weaker response dominated by IgM antibodies, with little memory. Conjugating polysaccharides to protein carriers converts them into T-dependent antigens, inducing stronger, longer-lasting immunity with class switching and memory formation. Cytotoxic T cells and Th17 responses are not the main outcomes of pure polysaccharide vaccines. This is why modern vaccines often use conjugates to improve efficacy, especially in children.

Q28. Which organ acts as a major filter for blood-borne antigens?

A) Lymph nodes
B) Thymus
C) Spleen
D) Bone marrow

Answer: C) Spleen

Explanation:
The spleen filters blood, removing old red blood cells and trapping blood-borne pathogens for immune surveillance. It contains white pulp (lymphoid tissue) and red pulp (filtering blood cells). Lymph nodes filter lymph, not blood. The thymus is for T cell maturation, and bone marrow is for hematopoiesis. Splenectomy patients are more vulnerable to infections from encapsulated bacteria (like Streptococcus pneumoniae), which is why they require special vaccinations. The spleen is therefore crucial for systemic immunity against blood pathogens.

Q29. Which mechanism is the main way cytotoxic T lymphocytes induce apoptosis in infected cells?

A) Fas–FasL interaction and perforin–granzyme pathway
B) Release of antibodies
C) Production of histamine
D) Secretion of IL-4

Answer: A) Fas–FasL interaction and perforin–granzyme pathway

Explanation:
Cytotoxic T cells induce apoptosis mainly via two mechanisms: perforin creates pores in the target cell membrane, allowing granzymes to enter and activate caspases, while FasL on T cells binds Fas receptors on target cells, triggering programmed cell death. These ensure controlled elimination of infected or malignant cells without widespread inflammation. Antibody release is a B cell function, histamine comes from mast cells, and IL-4 is a Th2 cytokine. CTL apoptosis pathways are vital in controlling viral infections and tumor surveillance.

Q30. Which condition is associated with uncontrolled complement activation due to C1 inhibitor deficiency?

A) Systemic lupus erythematosus
B) Hereditary angioedema
C) Rheumatoid arthritis
D) Multiple sclerosis

Answer: B) Hereditary angioedema

Explanation:
Hereditary angioedema is caused by deficiency or dysfunction of C1 esterase inhibitor, a regulator of the classical complement pathway. Without this inhibitor, uncontrolled bradykinin and complement activation lead to recurrent episodes of swelling in the skin, gastrointestinal tract, and airway. This condition can be life-threatening if laryngeal edema occurs. SLE is associated with immune complex deposition, RA with autoimmune joint inflammation, and MS with T cell–mediated demyelination. C1 inhibitor replacement therapy is used to treat hereditary angioedema.